SEC Form 4 · accession 0001127602-17-012396

CVS HEALTH Corp · CVS

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — EVP, Cont & Chief Acct Officer

Period of report

Mar 17, 2017

Accepted (ET)

Mar 20, 2017 · 4:24 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000064803

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Mar 17, 2017	M	6,029	$34.96	A	41,614	D
Common Stock	Mar 17, 2017	S	6,029	$79.60	D	35,585	D
Common Stock (restricted)	holding	—	—		—	16,831	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option^F2	$34.96	Mar 17, 2017	M	6,029	D	Apr 1, 2012	Apr 1, 2018	Common Stock	6,029	0	D
Stock Option^F3	$45.07	holding	—	—	—	Apr 2, 2013	Apr 2, 2019	Common Stock	13,311	13,311	D
Stock Option^F4	$54.53	holding	—	—	—	Apr 1, 2014	Apr 1, 2020	Common Stock	13,278	13,278	D
Stock Option^F5	$74.29	holding	—	—	—	Apr 1, 2015	Apr 1, 2021	Common Stock	18,882	18,882	D
Stock Option^F6	$102.26	holding	—	—	—	Apr 1, 2016	Apr 1, 2022	Common Stock	27,392	27,392	D
Stock Option^F7	$104.82	holding	—	—	—	Apr 1, 2017	Apr 1, 2023	Common Stock	21,509	21,509	D

F1All sales were effected pursuant to a Rule 10b5-1 plan.
F2Option became exercisable in four equal annual installments, commencing 4/1/2012.
F3Option became exercisable in four equal annual installments, commencing 4/2/2013.
F4Option became exercisable in four equal annual installments, commencing 4/1/2014.
F5Option became exercisable in four equal annual installments, commencing 4/1/2015.
F6Option became exercisable in four equal annual installments, commencing 4/1/2016.
F7Option becomes exercisable in four equal annual installments, commencing 4/1/2017.